InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,220.00
(
-0.20%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,300.00
(
0.33%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Gold Seeker

Send PM Follow Ignore
Followers 29
Posts 9421
Boards Moderated 0
Alias Born 04/30/2006

Gold Seeker

Re: Gold Seeker post# 23636

Monday, 06/30/2014 2:44:23 PM

Monday, June 30, 2014 2:44:23 PM

Post# of 30046
The prostate cancer test they are hyping is horribly inaccurate.

specificity 73%

So, lets take 2000 men off the street and test them. Sere data shows that 3 of the 2000 men would have an undetected new positive case of prostate cancer.

The sensitivity is 71% so it probably would find only 2 of the 3 who had prostate cancer.

The big problem is the false positives. Of the 2000 men tested, 540 would test positive and only 2 of the 3 actualy cases would have been detected.

This test SUCKS and would be a disaster for those taking the test.

This is just a scam to suck money from investors to pay bucks to those running the company.

The numbers tell the truth.

I have never shorted nor intend to have any financial interest in this stock. I am not connected with anyone who trades, shorts or has financial interests in this stock. I only post facts and my opinions. I do not post on IHUB with different aliases.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up